Capital Performance Advisors LLP Ark Genomic Revolution ETF (De Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Capital Performance Advisors LLP holds 27 shares of ARKG stock, worth $624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$624% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
292Shares Held
21MCall Options Held
2.79MPut Options Held
6.56M-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$63.7 Million3.23% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$52.2 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$40.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$35.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$33.7 Million0.0% of portfolio